New spinal implant aims to ease back pain from worn discs

NCT ID NCT05997121

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing the safety and performance of a spinal implant called the Hexanium TLIF system in adults with degenerative disc disease. The implant is placed during surgery to fuse the spine and restore disc height. Researchers will track pain, disability, and any serious side effects for up to two years after surgery. The goal is to see if this device helps patients feel better and function more normally.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Hexanium TLIF system (a spinal implant device used in surgery to fuse vertebrae)
What this could lead to
If successful, this could confirm that the Hexanium TLIF system is a safe and effective option for treating degenerative disc disease, helping patients experience less back and leg pain and improved function.
What could go wrong
This is an observational study, not a randomized trial, so results may be less definitive. Risks include surgery-related complications like infection or implant failure, and the device may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEGENERATIVE DISC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHRU Nancy

    RECRUITING

    Nancy, France

  • Clinicque Générale Beaulieu

    NOT_YET_RECRUITING

    Geneva, Switzerland

  • Clinique Saint Charles

    RECRUITING

    Lyon, France

  • Clinique du dos Terrefort

    RECRUITING

    Bruges, France

  • Hopital privé Clairval

    RECRUITING

    Marseille, France

  • Polyclinique Majorelle

    RECRUITING

    Nancy, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.